down arrow

Shaanxi Meibang Pharmaceutical Group Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE100005071
CNY
19.48
-0.05 (-0.26%)

Sep 24

SHG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Why is Shaanxi Meibang Pharmaceutical Group Co., Ltd. ?

1
Poor Management Efficiency with a low ROCE of 8.59%
  • The company has been able to generate a Return on Capital Employed (avg) of 8.59% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
  • Poor long term growth as Net Sales has grown by an annual rate of -2.41% and Operating profit at -26.85% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 7.87% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -2.41% and Operating profit at -26.85% over the last 5 years
4
With ROE of 4.42%, it has a fair valuation with a 1.93 Price to Book Value
  • Over the past year, while the stock has generated a return of -10.01%, its profits have risen by 139.8% ; the PEG ratio of the company is 0.3
5
Underperformed the market in the last 1 year
  • Even though the market (China Shanghai Composite) has generated returns of 3.23% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -10.01% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shaanxi Meibang Pharmaceutical Group Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shaanxi Meibang Pharmaceutical Group Co., Ltd.
-11.29%
1.19
45.64%
China Shanghai Composite
0.9%
0.22
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-2.41%
EBIT Growth (5y)
-26.85%
EBIT to Interest (avg)
53.25
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.62
Tax Ratio
16.47%
Dividend Payout Ratio
41.67%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.52%
ROE (avg)
7.87%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
44
Industry P/E
Price to Book Value
1.93
EV to EBIT
39.96
EV to EBITDA
26.86
EV to Capital Employed
2.20
EV to Sales
2.12
PEG Ratio
0.31
Dividend Yield
0.22%
ROCE (Latest)
5.51%
ROE (Latest)
4.42%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
PRE-TAX PROFIT(Q)

At CNY 16.35 MM has Grown at 210.73%

ROCE(HY)

Highest at 5.44%

NET PROFIT(Q)

At CNY 15.88 MM has Grown at 190.29%

RAW MATERIAL COST(Y)

Fallen by -21.33% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 4.11 times

-8What is not working for the Company
INTEREST(9M)

At CNY 0.69 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Lowest at CNY 124.46 MM

DEBT-EQUITY RATIO (HY)

Highest at -9.68 %

Here's what is working for Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Pre-Tax Profit
At CNY 16.35 MM has Grown at 210.73%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 15.88 MM has Grown at 190.29%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Inventory Turnover Ratio
Highest at 4.11 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -21.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Interest
At CNY 0.69 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY 124.46 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debt-Equity Ratio
Highest at -9.68 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Footer loading